M4MM

Tilray Medical Expands to Panama Market

NEW YORK – Tilray Medical, the pharmaceutical arm of Tilray Brands Inc., has secured a medical Cannabis license in Panama, marking its latest step into Central America. The company formed a joint venture with local ...

Willow Biosciences Reports Q3 2024

LOS ANGELES- Willow Biosciences Inc., a biotechnology firm specializing in the industrial production of functional ingredients, has reported its financial results for the third quarter of 2024. The company achieved record revenue of $1.7 million ...

DEA Schedules Cannabis Rescheduling Hearings for Early 2025

LOS ANGELES- The Drug Enforcement Administration (DEA) has outlined a schedule for witness testimony in the ongoing hearing concerning the potential reclassification of cannabis under the Controlled Substances Act. Chief Administrative Law Judge John Mulrooney ...

Week’s In Review: Ohio Legislature Considers Ban on Intoxicating Hemp Products; Florida’s Cannabis Legalization Measure Fails Despite Majority Support; Climate First Bank Introduces Cannabis-Focused Financial Services in Florida; DEA Postpones Cannabis Rescheduling Hearings to 2025

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Subscribe To Our Newsletter